BR112012009033A2 - composições e métodos de profilaxia para dermatite de contato - Google Patents

composições e métodos de profilaxia para dermatite de contato

Info

Publication number
BR112012009033A2
BR112012009033A2 BR112012009033A BR112012009033A BR112012009033A2 BR 112012009033 A2 BR112012009033 A2 BR 112012009033A2 BR 112012009033 A BR112012009033 A BR 112012009033A BR 112012009033 A BR112012009033 A BR 112012009033A BR 112012009033 A2 BR112012009033 A2 BR 112012009033A2
Authority
BR
Brazil
Prior art keywords
methods
contact dermatitis
prophylaxis
compositions
prophylaxis compositions
Prior art date
Application number
BR112012009033A
Other languages
English (en)
Inventor
M Karp Jeffrey
Kumar Vemula Praveen
Rox Anderson Richard
Original Assignee
Brigham & Womens Hospital Inc
Massachusetts Gen Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital Inc, Massachusetts Gen Hospital filed Critical Brigham & Womens Hospital Inc
Publication of BR112012009033A2 publication Critical patent/BR112012009033A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR112012009033A 2009-10-02 2010-10-01 composições e métodos de profilaxia para dermatite de contato BR112012009033A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24802309P 2009-10-02 2009-10-02
PCT/US2010/051125 WO2011041680A2 (en) 2009-10-02 2010-10-01 Compositions and methods of prophylaxis for contact dermatitis

Publications (1)

Publication Number Publication Date
BR112012009033A2 true BR112012009033A2 (pt) 2017-06-06

Family

ID=43826906

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012009033A BR112012009033A2 (pt) 2009-10-02 2010-10-01 composições e métodos de profilaxia para dermatite de contato

Country Status (4)

Country Link
US (2) US20120321573A1 (pt)
EP (1) EP2482807A4 (pt)
BR (1) BR112012009033A2 (pt)
WO (1) WO2011041680A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201122220D0 (en) * 2011-12-23 2012-02-01 Croda Int Plc Novel emoillients
FR2993466B1 (fr) * 2012-07-18 2014-08-15 Prevor Internat Utilisation d'une creme de protection contre les effets des agents chimiques agressifs en contact avec la peau
WO2015088445A1 (en) * 2013-12-13 2015-06-18 Nanyang Technological University Multilayered nanoparticle and methods of manufacturing and using the same
FR3021045B1 (fr) * 2014-05-16 2020-02-21 Solvay Sa Procede de production d'un reactif phosphocalcique, reactif obtenu et son utilisation
US11439583B2 (en) * 2014-08-05 2022-09-13 Amantin Experts Protective skin compositions
US11440927B2 (en) 2017-11-28 2022-09-13 International Business Machines Corporation Hydroxyapatite janus particles
CN109966545A (zh) * 2019-02-27 2019-07-05 韩建中 一种基于3d打印技术的环保型抗菌抗感染的创面愈合敷料
CN114163925B (zh) * 2021-12-06 2022-06-10 中国科学院兰州化学物理研究所 一种在通用器材表面修饰水凝胶润滑涂层的方法及修饰有水凝胶润滑涂层的通用器材

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005191A (en) * 1974-06-04 1977-01-25 Clark Mary G Topical ointment composition
US5460831A (en) * 1990-06-22 1995-10-24 The Regents Of The University Of California Targeted transfection nanoparticles
US6579891B1 (en) 1995-12-29 2003-06-17 Novactyl, Inc. Agent and method for prevention and treatment of cancer in animals
SE9604610D0 (sv) 1996-12-16 1996-12-16 Noviscens Ab Medical composition
DE19802539B4 (de) * 1998-01-23 2006-05-11 Jarisch, Reinhart, Dr. Verwendung von Diethylentriamin-Pentaessigsäure zum Herstellen einer Schutzcreme gegen Kontaktdermatitis
US6441009B1 (en) * 1998-08-01 2002-08-27 Novactyl, Inc. Agent and method of preventing and treating heavy metal exposure and toxicity
CO5111023A1 (es) * 1998-12-31 2001-12-26 Kimberly Clark Co Composicion de articulo absorbente y metodo para usarla para secuestrar irritantes de la piel
US20040258763A1 (en) 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
US6403618B1 (en) 2000-02-15 2002-06-11 Novactyl, Inc. Agent and method for controlling angiogenesis
WO2003072072A1 (en) * 2002-02-26 2003-09-04 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method of stimulation of melanin production and induction of skin tanning
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20050100621A1 (en) * 2003-11-07 2005-05-12 Popp Karl F. Dermatological compositions
CA2555121A1 (en) 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
WO2006050368A2 (en) * 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles iin use for aesthetic or cosmetic medicine, and methods of manufacture and use
GB0425945D0 (en) * 2004-11-26 2004-12-29 Unilever Plc Underarm cosmetic method and compositions
US20060270752A1 (en) * 2005-05-26 2006-11-30 Ada Foundation Dental releasing materials
DK2029480T3 (en) 2006-05-30 2017-08-14 Coswell Spa Biologically active nanoparticles of a carbonate-substituted hydroxyapatite, process for their preparation, and compositions comprising the same.
US20080241256A1 (en) * 2007-03-30 2008-10-02 Liisa Kuhn Targeted active agent delivery system based on calcium phosphate nanoparticles

Also Published As

Publication number Publication date
WO2011041680A2 (en) 2011-04-07
US20160228550A1 (en) 2016-08-11
EP2482807A4 (en) 2013-04-24
EP2482807A2 (en) 2012-08-08
US20120321573A1 (en) 2012-12-20
WO2011041680A3 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
BRPI1010815A2 (pt) óxido de grafeno altamente oxidado e métodos para produção do mesmo
SMT201600307B (it) Composizione liposomiale
BRPI1006800A2 (pt) artigos absorventes para vestir em duas peças
BRPI1012525A2 (pt) composições de nanopatículas isentas de príons e métodos para sua fabricação
BR112012024303A2 (pt) composição modificada para impacto e artigo fabricado
BRPI1008326A2 (pt) Composições e métodos para controlar nanatódeos
BR112012009033A2 (pt) composições e métodos de profilaxia para dermatite de contato
BRPI1013588A2 (pt) composição
BRPI1011325A2 (pt) composições e métodos para o tratamento de inflamação
BR112012000171A2 (pt) composição lubrificante, e, método
BRPI1015474A2 (pt) composição
BR112014015186A2 (pt) composição de graxa
BR112013014825A2 (pt) composição de graxa
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
BRPI1009141A2 (pt) composições e métodos para profilaxia e tratamento de vícios
BRPI1013927A2 (pt) métodos e composições para o tratamento de lúpus
BR112013012583A2 (pt) composições de limpeza diluíveis e métodos para utilização
DK2431450T3 (da) Bionedbrydelig smøremiddelsammensætning
BR112012004699A2 (pt) Métodos e composições para lise química direta
BR112012006437A2 (pt) composições e métodos para tratamento do diabetes e outros distúrbios
BRPI1005290A2 (pt) composição
BRPI1007471A2 (pt) composições de enxágue para cuidados pessoais
BRPI1007969A2 (pt) extratos de cajanus e glucosamina para desordens inflamatórias.
BR112012000955A2 (pt) composição lubrificante
BRPI1010888A2 (pt) composicao lubrificante

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]